Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1995 2
1996 1
1998 1
1999 3
2000 2
2001 1
2003 1
2004 4
2005 1
2006 2
2008 2
2009 1
2012 1
2013 1
2014 1
2015 2
2017 1
2018 2
2020 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Effects of safinamide on the glutamatergic striatal network in experimental Parkinson's disease.
Sciaccaluga M, Mazzocchetti P, Bastioli G, Ghiglieri V, Cardinale A, Mosci P, Caccia C, Keywood C, Melloni E, Padoani G, Vailati S, Picconi B, Calabresi P, Tozzi A. Sciaccaluga M, et al. Among authors: vailati s. Neuropharmacology. 2020 Jun 15;170:108024. doi: 10.1016/j.neuropharm.2020.108024. Epub 2020 Mar 3. Neuropharmacology. 2020. PMID: 32142791
Safinamide's potential in treating nondystrophic myotonias: Inhibition of skeletal muscle voltage-gated sodium channels and skeletal muscle hyperexcitability in vitro and in vivo.
Desaphy JF, Farinato A, Altamura C, De Bellis M, Imbrici P, Tarantino N, Caccia C, Melloni E, Padoani G, Vailati S, Keywood C, Carratù MR, De Luca A, Conte D, Pierno S. Desaphy JF, et al. Among authors: vailati s. Exp Neurol. 2020 Jun;328:113287. doi: 10.1016/j.expneurol.2020.113287. Epub 2020 Mar 20. Exp Neurol. 2020. PMID: 32205118
31 results